BIRC5 and breast cancer: Eugenol (4-allyl-1-hydroxy-2-methoxybenzene), the main constituent of clove (Syzygium aromaticum), has been shown to target and inhibit survivin in breast cancer cells, thus inducing apoptosis and tumor inhibition [15].